Neurophysiology Biomarkers of Cognitive Impairment Associated With Deep Brain Stimulation

Sponsor
Vanderbilt University Medical Center (Other)
Overall Status
Recruiting
CT.gov ID
NCT05933681
Collaborator
(none)
160
1
2
24
6.7

Study Details

Study Description

Brief Summary

The study aims to investigate cognitive impairment associated with Deep Brain Stimulation (DBS) in Parkinson's Disease patients, with a focus on identifying neurophysiology biomarkers of DBS associated cognitive changes. Using neurophysiology data recorded during DBS surgeries and post-implantation, the research intends to identify biomarkers in order to optimize electrode placement, enhance programming, and ultimately minimize DBS-related cognitive side effects.

Condition or Disease Intervention/Treatment Phase
  • Device: Neural recordings and stimulation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
160 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
Neurophysiology Biomarkers of Cognitive Impairment Associated With Deep Brain Stimulation
Anticipated Study Start Date :
Jul 1, 2023
Anticipated Primary Completion Date :
Jun 30, 2025
Anticipated Study Completion Date :
Jun 30, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Determination of DLPFC neurophysiology biomarkers of DBS associated cognitive impairment

Neurophysiology recordings will be performed from dorsolateral prefrontal cortex (DLPFC) during deep brain stimulation surgery, with and without STN or GPI stimulation, at rest and during a working memory task.

Device: Neural recordings and stimulation
Neural activities from the dorsolateral prefrontal cortex and implanted DBS generator will be recorded, during resting and working memory tasks, and with the DBS target turned on and off.

Experimental: Neurophysiology biomarkers of DBS mediated cognitive impairment following chronic stimulation

Neurophysiology recordings will be performed from subthalamic nucleus (STN) or globus pallidus internus (GPI) with stimulation on and off, at rest and during a working memory task, in patients who have previously been implanted with DBS and have implantable pulse generators capable of recording local field potentials.

Device: Neural recordings and stimulation
Neural activities from the dorsolateral prefrontal cortex and implanted DBS generator will be recorded, during resting and working memory tasks, and with the DBS target turned on and off.

Outcome Measures

Primary Outcome Measures

  1. Determination of DLPFC beta power a biomarker of DBS associated cognitive impairment in the acute stimulation setting [Baseline to end of Deep Brain Stimulation (DBS), approximately 3-4 hours]

    Working memory tasked will be conducted during surgery, and local field potentials (LFPs) will be recorded from the DLPFC both at rest and during task execution, under two conditions: with and without stimulation.

  2. Determination of STN local field potential biomarkers of DBS mediated cognitive impairment following chronic stimulation [1 hour]

    Local field potentials will be recorded from subthalamic nucleus or globus pallidus internus in patients with an existing DBS system with implantable pulse generator capable of recording local field potentials. Recordings will be performed at rest and during a working memory task, with DBS on and off.

Eligibility Criteria

Criteria

Ages Eligible for Study:
40 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

• Scheduled to undergo deep brain stimulation surgery under local anesthesia at Vanderbilt University Medical Center (Arm 1)

  • Active deep brain stimulation system with implantable pulse generator capable of recording local field potentials (Arm 2)

  • Diagnosis of Parkinson's disease as determined by a movement disorders specialist neurologist

  • Age at least 18

  • Able to participate in intraoperative testing

  • English speaking

Exclusion Criteria:
  • Age less than 18

  • Not able to participate in intraoperative testing (ex unable to comprehend instructions or follow directions)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Vanderbilt University Medical Center Nashville Tennessee United States 37232

Sponsors and Collaborators

  • Vanderbilt University Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sarah Bick, Assistant Professor of Neurosurgery, Vanderbilt University Medical Center
ClinicalTrials.gov Identifier:
NCT05933681
Other Study ID Numbers:
  • 230539
First Posted:
Jul 6, 2023
Last Update Posted:
Jul 6, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sarah Bick, Assistant Professor of Neurosurgery, Vanderbilt University Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 6, 2023